SARS-CoV-2-specific CD8 <sup>+</sup> T cells from people with long COVID establish and maintain effector phenotype and key TCR signatures over 2 years
Long COVID occurs in a small but important minority of patients following COVID-19, reducing quality of life and contributing to healthcare burden. Although research into underlying mechanisms is evolving, immunity is understudied. SARS-CoV-2-specific T cell responses are of key importance for viral clearance and COVID-19 recovery. However, in long COVID, the establishment and persistence of SARS-CoV-2-specific T cells are far from clear, especially beyond 12 mo postinfection and postvaccination. We defined ex vivo antigen-specific B cell and T cell responses and their T cell receptors (TCR) repertoires across 2 y postinfection in people with long COVID. Using 13 SARS-CoV-2 peptide-HLA tetramers, spanning 11 HLA allotypes, as well as spike and nucleocapsid probes, we tracked SARS-CoV-2-specific CD8<sup>+</sup> and CD4<sup>+</sup> T cells and B-cells in individuals from their first SARS-CoV-2 infection through primary vaccination over 24 mo. The frequencies of ORF1a- and nucleocapsid-specific T cells and B cells remained stable over 24 mo. Spike-specific CD8<sup>+</sup> and CD4<sup>+</sup> T cells and B cells were boosted by SARS-CoV-2 vaccination, indicating immunization, in fully recovered and people with long COVID, altered the immunodominance hierarchy of SARS-CoV-2 T cell epitopes. Meanwhile, influenza-specific CD8<sup>+</sup> T cells were stable across 24 mo, suggesting no bystander-activation. Compared to total T cell populations, SARS-CoV-2-specific T cells were enriched for central memory phenotype, although the proportion of central memory T cells decreased following acute illness. Importantly, TCR repertoire composition was maintained throughout long COVID, including postvaccination, to 2 y postinfection. Overall, we defined ex vivo SARS-CoV-2-specific B cells and T cells to understand primary and recall responses, providing key insights into antigen-specific responses in people with long COVID.
Authors
- Prathanporn Kaewpreedee (ORCID: https://orcid.org/0000-0002-0464-2401)
- Adam K. Wheatley (ORCID: https://orcid.org/0000-0002-5593-9387)
- Katherine Kedzierska (ORCID: https://orcid.org/0000-0001-6141-335X)
- Malik Peiris (ORCID: https://orcid.org/0000-0001-8217-5995)
- Samuel M. S. Cheng (ORCID: https://orcid.org/0000-0001-7293-2331)
- Jennifer R. Habel (ORCID: https://orcid.org/0000-0003-0380-1527)
- Jan Petersen (ORCID: https://orcid.org/0000-0002-2045-6342)
- Priyanka Chaurasia (ORCID: https://orcid.org/0000-0002-3755-159X)
- Dhilshan Jayasinghe
- Thi H. O. Nguyen (ORCID: https://orcid.org/0000-0002-9294-7693)
- Allen Cheng (ORCID: https://orcid.org/0000-0003-3152-116X)
- Leo L. M. Poon (ORCID: https://orcid.org/0000-0002-9101-7953)
- Jason A. Trubiano (ORCID: https://orcid.org/0000-0002-5111-6367)
- Isabelle J. H. Foo (ORCID: https://orcid.org/0000-0002-4465-7245)
- Hayley A. McQuilten (ORCID: https://orcid.org/0000-0002-7089-5300)
- Jennifer A. Juno (ORCID: https://orcid.org/0000-0002-9072-1017)
- Lydia Murdiyarso
- Louise C. Rowntree (ORCID: https://orcid.org/0000-0002-0649-5089)
- Stephen John Kent (ORCID: https://orcid.org/0000-0002-8539-4891)
- Sophie A. Valkenburg (ORCID: https://orcid.org/0000-0002-0768-9926)
- Janette Kwok (ORCID: https://orcid.org/0000-0003-0038-1897)
- Jennifer Audsley (ORCID: https://orcid.org/0000-0001-6322-3197)
- Sharon R. Lewin (ORCID: https://orcid.org/0000-0002-0330-8241)
- Hyon‐Xhi Tan (ORCID: https://orcid.org/0000-0003-1064-3934)
- Dene R. Littler (ORCID: https://orcid.org/0000-0001-5904-1905)
- Peter C. Doherty (ORCID: https://orcid.org/0000-0002-5028-3489)
- Wuji Zhang (ORCID: https://orcid.org/0000-0001-7460-4956)
- Natasha E. Holmes (ORCID: https://orcid.org/0000-0001-8501-4054)
- Jamie Rossjohn (ORCID: https://orcid.org/0000-0002-2020-7522)
- Ruth R. Hagen (ORCID: https://orcid.org/0000-0003-4437-2458)
- Stéphanie Gras (ORCID: https://orcid.org/0000-0001-7416-038X)
- David S.C. Hui (ORCID: https://orcid.org/0000-0003-4382-2445)
- Ka Pang Chan (ORCID: https://orcid.org/0000-0002-8163-5846)
- Irani Thevarajan
- Tom Kotsimbos
- Kelly W. K. Lee
- Elizabeth R. V. ten Berge
- Lilith F. Allen (ORCID: https://orcid.org/0000-0002-4197-2573)
- Hanujah Ganesh
Institutions
- The Royal Melbourne Hospital (AU)
- The University of Melbourne (AU)
- Chinese University of Hong Kong (HK)
- La Trobe University (AU)
- Peter MacCallum Cancer Centre (AU)
- Queen Mary Hospital (CN)
- Hong Kong Science and Technology Parks Corporation (HK)
- Australian Regenerative Medicine Institute (AU)
- The Alfred Hospital (AU)
- Peter Doherty Institute (AU)
- Prince of Wales Hospital (CN)
- Monash Health (AU)
- HKU-Pasteur Research Pole (HK)
- Austin Health (AU)
- Monash University (AU)
- Cardiff University (GB)
- University of Hong Kong (HK)
Publication Details
- Journal
- Proceedings of the National Academy of Sciences
- Published
- 2024-09-16
- DOI
- https://doi.org/10.1073/pnas.2411428121
- Citations
- 15
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 5.54
Funders
- Snow Medical
- National Health and Medical Research Council
- Health and Medical Research Fund